ATE293964T1 - Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste - Google Patents

Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste

Info

Publication number: ATE293964T1
Authority: AT; Austria
Prior art keywords: compositions; methods; nematokyste; effective amount; inhibiting
Prior art date: 1997-05-29

Application number

AT98925037T

Other languages

English (en)

Inventor

Amit Lotan

Original Assignee

Nidaria Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-29

Filing date

1998-05-28

Publication date

2005-05-15

1997-05-29 Priority claimed from US08/865,332 external-priority patent/US6132747A/en

1998-05-28 Application filed by Nidaria Technology Ltd filed Critical Nidaria Technology Ltd

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE293964T1 publication Critical patent/ATE293964T1/de

Links

239000000203 mixture Substances 0.000 title abstract 4
230000002401 inhibitory effect Effects 0.000 title abstract 3
239000002775 capsule Substances 0.000 abstract 3
210000002484 nematocyst Anatomy 0.000 abstract 3
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 2
230000001387 anti-histamine Effects 0.000 abstract 2
239000000739 antihistaminic agent Substances 0.000 abstract 2
150000001768 cations Chemical class 0.000 abstract 2
239000002674 ointment Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT98925037T 1997-05-29 1998-05-28 Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste ATE293964T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/865,332 US6132747A (en)	1997-05-29	1997-05-29	Compositions and methods for inhibiting nematocyst discharge
US08/947,077 US6338837B1 (en)	1997-05-29	1997-10-08	Compositions and methods for inhibiting nematocyst discharge
PCT/US1998/011029 WO1998053807A1 (en)	1997-05-29	1998-05-28	Compositions and methods for inhibiting nematocyst discharge

Publications (1)

Publication Number	Publication Date
ATE293964T1 true ATE293964T1 (de)	2005-05-15

Family

ID=27127893

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98925037T ATE293964T1 (de)	1997-05-29	1998-05-28	Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste

Country Status (8)

Country	Link
US (1)	US6338837B1 (de)
EP (1)	EP0984776B1 (de)
AT (1)	ATE293964T1 (de)
AU (1)	AU745348B2 (de)
DE (1)	DE69829963T2 (de)
ES (1)	ES2244063T3 (de)
IL (1)	IL133179A0 (de)
WO (1)	WO1998053807A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7632522B2 (en)	2000-09-28	2009-12-15	Nanocyte Inc.	Use of stinging cells/capsules for the delivery of active agents to keratinous substances
IL155097A0 (en) *	2000-09-28	2003-10-31	Nanocyte Inc	Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US20070281037A9 (en) *	2000-09-28	2007-12-06	Nanocyte Inc.	Sterile preparations and compositions including stinging capsules and methods of producing and using same
DE60320793D1 (de) *	2002-03-26	2008-06-19	Nanocyte Inc	Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe
US8834862B2 (en) *	2005-04-19	2014-09-16	Nanocyte Inc.	Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
US20080300790A1 (en) *	2007-05-29	2008-12-04	James Kirunda Kakaire	Environmental data delivery - edd
DE102009046697A1 (de) *	2009-11-13	2011-05-26	Carlos Guido Bittler	Mittel und Kit zur Behandlung von Vernesselungen, Insektenstichen und dgl.
ES2483152T3 (es)	2010-03-01	2014-08-05	Antonio Puig, S.A.	Composiciones anti-medusas
ES2444116T3 (es)	2010-04-21	2014-02-24	Antonio Puig, S.A.	Combinaciones antimedusas
US10172883B2 (en)	2014-06-10	2019-01-08	Alatalab Solution, Llc	Methods and compositions for treating and/or inhibiting toxins using copper-containing compounds
NO20160382A1 (no) *	2016-03-04	2017-09-05	Nordfjord Laks As	Preparat som inneholder sjøvann tilsatt en kaliumforbindelse
EP4311544A1 (de)	2022-07-29	2024-01-31	Isdin, S. A.	Verbindungen, die gegen quallenstiche nützlich sind
EP4311545A1 (de)	2022-07-29	2024-01-31	Isdin, S. A.	Verbindungen, die für die behandlung nach dem stechen von nesseltieren nützlich sind

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB813896A (en) *	1956-11-19	1959-05-27	Bristol Lab Inc	Stable aqueous preparations of calcium amphomycin
US4234566A (en) *	1979-06-29	1980-11-18	Packman Elias W	Antihistamine and methods for use thereof
AU8946582A (en)	1981-10-29	1983-05-05	Henderson, D.	Aluminium sulphate composition
GB2122893B (en) *	1982-06-30	1985-06-26	Biorex Laboratories Ltd	Glycyrrhetinic acid compositions
US4847083A (en) *	1986-04-02	1989-07-11	Dermasciences, Inc.	Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
US4917889A (en) *	1988-07-14	1990-04-17	Thomas W. Clarke	Topical composition and treatment
US4873265A (en)	1988-07-14	1989-10-10	Thomes Pharmacal Co., Inc.	Anti-infective methods and compositions
US4929619A (en)	1988-07-14	1990-05-29	Thames Pharmacal Co., Inc.	Anti-infective methods and compositions
US5401728A (en) *	1992-04-02	1995-03-28	Simon; John A.	Lecithin based topical liniment
DE4303983C2 (de)	1993-02-11	1998-01-22	Beiersdorf Ag	Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an anorganischen Mikropigmenten
US5561166A (en) *	1993-07-28	1996-10-01	Beiersdorf, Inc.	Urea/lactate topical compositions for dry skin
AU701917B2 (en)	1994-07-19	1999-02-11	Beiersdorf Aktiengesellschaft	Topical preparations having a protective action against cnidaria
US5756107A (en) *	1994-12-21	1998-05-26	Cosmederm Technologies	Formulations and methods for reducing skin irritation
EP0737471A3 (de) *	1995-04-10	2000-12-06	L'oreal	Verwendung von Erdalkalimetallsalze als TNF-alpha Inhibitor in einer topischen Zusammensetzung und die so hergestellte Zusammensetzung
US5676975A (en) *	1995-06-29	1997-10-14	Dezes; Alexander C.	Burn symptom relief composition and method of producing same
CN1163121A (zh) *	1996-04-19	1997-10-29	迟经惠	静脉炎外敷药

1997
- 1997-10-08 US US08/947,077 patent/US6338837B1/en not_active Expired - Lifetime
1998
- 1998-05-28 AT AT98925037T patent/ATE293964T1/de not_active IP Right Cessation
- 1998-05-28 AU AU77075/98A patent/AU745348B2/en not_active Ceased
- 1998-05-28 EP EP98925037A patent/EP0984776B1/de not_active Expired - Lifetime
- 1998-05-28 WO PCT/US1998/011029 patent/WO1998053807A1/en not_active Ceased
- 1998-05-28 ES ES98925037T patent/ES2244063T3/es not_active Expired - Lifetime
- 1998-05-28 DE DE69829963T patent/DE69829963T2/de not_active Expired - Lifetime
- 1998-05-28 IL IL13317998A patent/IL133179A0/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69829963D1 (de)	2005-06-02
EP0984776B1 (de)	2005-04-27
EP0984776A1 (de)	2000-03-15
ES2244063T3 (es)	2005-12-01
IL133179A0 (en)	2001-03-19
AU745348B2 (en)	2002-03-21
AU7707598A (en)	1998-12-30
DE69829963T2 (de)	2006-02-23
WO1998053807A1 (en)	1998-12-03
US6338837B1 (en)	2002-01-15

Legal Events

Date	Code	Title	Description
2005-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DK0873340T3 (da)	2002-05-21	Heterocyklisk substituerede cyclopentanforbindelser
PT966465E (pt)	2003-11-28	Inibidores do enzima imfdh
DE69939864D1 (de)	2008-12-18	Ppar-gamma modulatoren
DK0693073T3 (da)	1998-10-12	Bicykliske ansamyciner og deres anvendelse som antitumormidler
TR200000927T2 (tr)	2000-11-21	Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
EE200000488A (et)	2002-02-15	Fosfolipaasensüümide inhibiitorid ja farmatseutilised kompositsioonid
ATE293964T1 (de)	2005-05-15	Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
DE69824029D1 (de)	2004-06-24	Bicyclische kinase inhibitoren
TR200103428T2 (tr)	2002-04-22	IMPDH enzim inhibitörleri.
AP2000001996A0 (en)	2000-12-31	Heterocyclic inhibitors of P38.
BR0107943A (pt)	2003-01-28	Sìtios de entrada de ribossoma internos sintéticos e métodos de identificar os mesmos
TR199900049T2 (xx)	1999-04-21	Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler.
EA199800772A1 (ru)	1999-04-29	Производные 6-фенилпиридил-2-амина
IL141157A0 (en)	2002-02-10	Salt form of pantoprazole and pharmaceutical compositions containing the same
DE50112128D1 (de)	2007-04-12	Retardpartikeldispersion
EP1244452A4 (de)	2003-01-15	Urotensin-ii rezeptorantagonisten
SE9604348D0 (sv)	1996-11-26	Användning av hydroxyguanidiner
PT1060175E (pt)	2005-03-31	Inibidores de triptase
EA200000165A1 (ru)	2000-10-30	Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
ATE302002T1 (de)	2005-09-15	Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
BG105761A (en)	2002-03-29	Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
IL144199A0 (en)	2002-05-23	Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ES2088128T3 (es)	1996-08-01	Aminosulfonilureas inhibidoras de acat.
NO993784L (no)	1999-09-22	Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
MXPA03001455A (es)	2004-05-04	Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.